PD-1 蛋白
PDCD1 宿主: 人 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
PDCD1 宿主: 人 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
PDCD1 宿主: 人 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
PD-1 蛋白 by Grade
Find PD-1 蛋白 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
PD-1 蛋白 by Origin
Find PD-1 蛋白 for a variety of species such as anti-Human PD-1, anti-Mouse PD-1, anti-Rat PD-1. The species listed below are among those available. Click on a link to go to the corresponding products.
PD-1 蛋白 by Source
Here you will find PD-1 蛋白 proteins organized by several key sources. By clicking on a link, you can access the products. For additional sources, please use our search function.
PD-1 蛋白 by 蛋白类型
Here you can find PD-1 蛋白 proteins categorized by available protein types. Additional protein types can be located using our search function.
PD-1 蛋白 by 应用范围
Find PD-1 蛋白 validated for a specific application such as WB, ELISA, SDS, AP. Some of the available applications are listed below. Click on a link to go to the corresponding products.
PD-1 蛋白 by 生物活性
Find PD-1 蛋白 with a specific 生物活性. The 生物活性 listed below are among those available. Click on a link to go to the corresponding products.
Popular PD-1 蛋白
- (6)
- (6)
- (5)
- (4)
- (4)
- (4)
- (4)
- (4)
- (3)
- (3)
- (4)
- (3)
- (6)
- (3)
- (1)
- (1)
- (2)
- (2)
Latest Publications for our PD-1 蛋白
: "Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents. ..." in: Cancer immunology research, Vol. 9, Issue 12, pp. 1451-1464, (2022) (PubMed).: "Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors." in: JCI insight, Vol. 6, Issue 20, (2021) (PubMed).
: "Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth." in: Molecular therapy oncolytics, Vol. 17, pp. 9-20, (2020) (PubMed).
: "An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses." in: Nature communications, Vol. 11, Issue 1, pp. 1395, (2020) (PubMed).
: "Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors." in: EMBO molecular medicine, Vol. 12, Issue 6, pp. e11571, (2020) (PubMed).
: "Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity." in: Cancer immunology, immunotherapy : CII, (2020) (PubMed).
: "Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit." in: mAbs, (2019) (PubMed).
: "Comprehensive in vitro characterization of PD-L1 small molecule inhibitors. ..." in: Scientific reports, Vol. 9, Issue 1, pp. 12392, (2019) (PubMed).
: "A small-sized protein binder specific for human PD-1 effectively suppresses the tumour growth in tumour mouse model." in: Journal of drug targeting, pp. 1-9, (2019) (PubMed).
: "Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy." in: Nature communications, Vol. 10, Issue 1, pp. 3850, (2019) (PubMed).
Aliases for PD-1 蛋白
programmed cell death 1 (PDCD1) 蛋白programmed cell death 1 (Pdcd1) 蛋白
CD279 蛋白
hPD-1 蛋白
hPD-l 蛋白
Ly101 蛋白
PD-1 蛋白
PD1 蛋白
Pdc1 蛋白
SLEB2 蛋白
